Skip to main content

Ectopic Fat Deposition, Adiponectin and Insulin Resistance in Obese Adolescents

  • Chapter
Book cover Insulin Resistance

Part of the book series: Contemporary Endocrinology ((COE))

  • 1005 Accesses

Obesity is one of the most serious and urgent public health problems in both developed and developing countries (1). It has reached epidemic proportions in the United States. Since the 1970s, the prevalence of overweight doubled among children of 6 to 11 years of age and tripled among those 12 to 17 years of age (2). Among children aged 6 through 19 years in 2001–2002, 31.5% were at risk for overweight and 16.5% were overweight (more than 3 times the target prevalence of 5%) (3). Furthermore, the problem falls disproportionately on African-American and Hispanic children.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Strauss RS, Pollack HA. Epidemic increase in childhood overweight, 1986–1998. JAMA. 2001; 286 (22): 2845–2848

    Article  PubMed  CAS  Google Scholar 

  2. Flegal KM, Carroll MD, Ogden CL, Johnson CL. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002; 288 (14): 1723–1727

    Article  PubMed  Google Scholar 

  3. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004; 291 (23): 2847–2850

    Article  PubMed  CAS  Google Scholar 

  4. Kaufman FR. Type 2 diabetes in children and youth. Endocrinol Metab Clin North Am. 2005; 34 (3): 659–676

    Article  PubMed  Google Scholar 

  5. Weiss R, Dziura J, Burgert TS, Tamborlane WV, Taksali SE, Yeckel CW, Allen K, Lopes M, Savoye M, Morrison J, Sherwin RS, Caprio S. Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004; 350 (23): 2362–2374

    Article  PubMed  CAS  Google Scholar 

  6. Dietz WH Health consequences of obesity in youth: childhood predictors of adult disease. Pediatrics 1998; 101 (3 Pt 2): 518–525. Review

    PubMed  CAS  Google Scholar 

  7. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults, the Bogalusa Heart Study. N Engl J Med. 1998; 338 (23): 1650–1656

    Article  PubMed  CAS  Google Scholar 

  8. Cook S, Weitzman M, Auinger P, Nguyen M, Dietz WH. Prevalence of a metabolic syndrome phenotype in adolescents: findings from the third National Health and Nutrition Examination Survey, 1988–1994. Arch Pediatr Adolesc Med. 2003; 157 (8): 821–827

    Article  PubMed  Google Scholar 

  9. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA. 2003; 290 (14): 1884–1890

    Article  PubMed  CAS  Google Scholar 

  10. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A, Nathan D, Palmer J, Rizza R, Saudek C, Shaw J, Steffes M, Stern M, Tuomilehto J, Zimmet P ; Expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003; 26 (11): 3160–3167. Review

    Article  PubMed  Google Scholar 

  11. Goran MI, Bergman RN, Avila Q, Watkins M, Ball GD, Shaibi GQ, Weigensberg MJ, Cruz ML. Impaired glucose tolerance and reduced beta-cell function in overweight Latino children with a positive family history for type 2 diabetes. J Clin Endocrinol Metab. 2004; 89 (1): 207–212

    Article  PubMed  CAS  Google Scholar 

  12. Wiegand S, Maikowski U, Blankenstein O, Biebermann H, Tarnow P, Gruters A. Type 2 diabetes and impaired glucose tolerance in European children and adolescents with obesity–a problem that is no longer restricted to minority groups. Eur J Endocrinol. 2004; 151 (2): 199–206

    Article  PubMed  CAS  Google Scholar 

  13. Keamseng C, Likitmaskul S, Kiattisathavee P, et al. Risk of metabolic disturbance and diabetes development in Thai obese children, 29th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes, Saint-Malo, France, September 3–6, 2003

    Google Scholar 

  14. Lee W, Tang J, Karim H, et al. Abnormalities of glucose tolerance in severely obese Singapore children, 29th Annual Meeting of the International Society for Pediatric and Adolescent Diabetes, Saint-Malo, France, September 3–6, 2003

    Google Scholar 

  15. Weiss R, Taksali SE, Tamborlane WV, Burgert TS, Savoye M, Caprio S. Predictors of changes in glucose tolerance status in obese youth. Diabetes Care. 2005; 28 (4): 902–909

    Article  PubMed  Google Scholar 

  16. Goodpaster BH, Wolf D. Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes. Pediatr Diabetes 2004; 5 (4): 219–226. Review

    Article  PubMed  Google Scholar 

  17. Goodpaster BH, Kelley DE. Skeletal muscle triglyceride: marker or mediator of obesityinduced insulin resistance in type 2 diabetes mellitus? Curr Diab Rep. 2002; 2 (3): 216–222. Review

    Article  PubMed  Google Scholar 

  18. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI. Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med. 2004; 350 (7): 664–671

    Article  PubMed  CAS  Google Scholar 

  19. Perseghin G, Scifo P, C obelli F, De Pagliato E, Battezzati A, A rcelloni C, V anzulli A, T estolin G, Pozza G, Del Maschio A, Luzi L. Intramyocellular triglyceride content is a determinant of in vivo insulin resistance in humans: a 1H-13C nuclear magnetic resonance spectroscopy assessment in offspring of type 2 diabetic parents. Diabetes. 1999; 48 (8): 1600–1606

    Article  PubMed  CAS  Google Scholar 

  20. Kelley DE. Skeletal muscle fat oxidation: timing and flexibility are everything. J Clin Invest. 2005; 115 (7): 1699–1702. Review

    Article  PubMed  CAS  Google Scholar 

  21. Sinha R, Dufour S, P etersen KF, LeBon V, Enoksson S, Ma YZ, Savoye M, Rothman DL, Shulman GI, Caprio S. Assessment of skeletal muscle triglyceride content by (1)H nuclearA.M.G. Cali, S. Caprio magnetic resonance spectroscopy in lean and obese adolescents: relationships to insulin sensitivity, total body fat, and central adiposity. Diabetes. 2002; 51 (4): 1022–1027

    Article  PubMed  CAS  Google Scholar 

  22. Weiss R, Dufour S, Taksali SE, Tamborlane WV, Petersen KF, Bonadonna RC, Boselli L, Barbetta G, Allen K, Rife F, Savoye M, Dziura J, Sherwin R, Shulman GI, Caprio S . Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet. 2003; 362 (9388): 951–957

    Article  PubMed  CAS  Google Scholar 

  23. Shulman GI. Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy. Physiology (Bethesda). 2004; 19: 183–190. Review

    CAS  Google Scholar 

  24. Goodpaster BH, Wolf D. Skeletal muscle lipid accumulation in obesity, insulin resistance, and type 2 diabetes. Pediatr Diabetes 2004; 5 (4): 219–226. Review

    Article  PubMed  Google Scholar 

  25. Strauss RS. Childhood obesity. Pediatr Clin North Am; 2002; 49 (1): 175–201. Review 26. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346 (16): 1221–1231. Review. No abstract available

    Article  PubMed  Google Scholar 

  26. Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006; 118 (4): 1388–1393

    Article  PubMed  Google Scholar 

  27. Inzucchi SE, Petersen KF, Shulman GI. Nonalcoholic fatty liver disease. N Engl J Med. 2002; 347 (10): 768–769; author reply 768–769

    Article  PubMed  Google Scholar 

  28. Meltzer AA, Everhart JE. Association between diabetes and elevated serum alanine aminotransferase activity among Mexican Americans. Am J Epidemiol. 1997; 146 (7): 565–571

    PubMed  CAS  Google Scholar 

  29. Nadeau KJ, Klingensmith G, Zeitler P. Type 2 diabetes in children is frequently associated with elevated alanine aminotransferase. J Pediatr Gastroenterol Nutr. 2005; 41 (1): 94–98

    Article  PubMed  CAS  Google Scholar 

  30. Kawasaki T, Hashimoto N, Kikuchi T, Takahashi H, Uchiyama M. The relationship between fatty liver and hyperinsulinemia in obese Japanese children. J Pediatr Gastroenterol Nutr. 1997; 24 (3): 317–321

    Article  PubMed  CAS  Google Scholar 

  31. Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, Chan IH, Yin J, Lam CW, Fok TF, Nelson EA. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord. 2004; 28 (10): 1257–1263

    Article  PubMed  CAS  Google Scholar 

  32. Schwimmer JB, Deutsch R, Rauch JB, Behling C, Newbury R, Lavine JE. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr. 2003; 143 (4): 500–505

    Article  PubMed  Google Scholar 

  33. Burgert TS, Taksali SE, Dziura J, Goodman TR, Yeckel CW, Papademetris X, Constable RT, Weiss R, Tamborlane WV, Savoye M, Seyal AA, Caprio S. Alanine Aminotransferase levels and fatty liver in childhood obesity:Associations with insulin resistance, adiponectin, and visceral fat. J Clin Endocrinol Metab. 2006; [Epub ahead of print]

    Google Scholar 

  34. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003; 37 (4): 917–923. Erratum in: Hepatology. 2003; 38 (2): 536

    Article  PubMed  Google Scholar 

  35. Sabir N, Sermez Y, Kazil S, Zencir M. Correlation of abdominal fat accumulation and liver steatosis: importance of ultrasonographic and anthropometric measurements. Eur J Ultrasound. 2001; 14 (2–3): 121–128

    Article  PubMed  CAS  Google Scholar 

  36. Busetto L, Tregnaghi A, Marchi F, De Segato G, Foletto M, Sergi G, Favretti F, Lise M, Enzi G. Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res. 2002; 10 (5): 408–411

    Article  PubMed  Google Scholar 

  37. Fishbein MH, Mogren C, Gleason T, Stevens WR. Relationship of hepatic steatosis to adipose tissue distribution in pediatric nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr. 2006; 42 (1): 83–88

    PubMed  Google Scholar 

  38. Matsuzawa Y, Nakamura T, Shimomura I, Kotani K. Visceral fat accumulation and cardiovascular disease. Obes Res. 1995; 3 Suppl 5: 645S–647S. Review

    PubMed  Google Scholar 

  39. Caprio S, Hyman LD, Limb C, McCarthy S, Lange R, Sherwin RS, Shulman G, Tamborlane WV. Central adiposity and its metabolic correlates in obese adolescent girls. Am J Physiol 1995; 269 (1 Pt 1): E118–E126 9 Ectopic Fat Deposition, Adiponectin and Insulin 159

    PubMed  CAS  Google Scholar 

  40. Cruz ML, Bergman RN, Goran MI. Unique effect of visceral fat on insulin sensitivity in obese Hispanic children with a family history of type 2 diabetes. Diabetes Care. 2002; 25 (9): 1631–1636

    Article  PubMed  Google Scholar 

  41. Ford ES. National Health and Nutrition Examination Survey. C-reactive protein concentration and cardiovascular disease risk factors in children: findings from the National Health and Nutrition Examination Survey 1999–2000. Circulation. 2003; 108 (9): 1053–1058. Epub 2003 Aug 18

    Article  PubMed  CAS  Google Scholar 

  42. Trayhurn P, Wood IS. A dipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004; 92: 347–355

    Article  PubMed  CAS  Google Scholar 

  43. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000; 148 (2): 209–214. Review

    Article  PubMed  CAS  Google Scholar 

  44. Tschritter O, Fritsche A, Thamer C, Haap M, Shirkavand F, Rahe S, S taiger H, M aerker E, Haring H, Stumvoll M. P lasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes. 2003; 52 (2): 239–243

    Article  PubMed  CAS  Google Scholar 

  45. Weiss R, Dufour S, Groszmann A, Petersen K, Dziura J, Taksali SE, Shulman G, C aprio S. Low adiponectin levels in adolescent obesity: a marker of increased intramyocellular lipid accumulation. J Clin Endocrinol Metab. 2003; 88 (5): 2014–2018.

    Article  PubMed  CAS  Google Scholar 

  46. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 2001; 7 (8): 941–946

    Article  PubMed  CAS  Google Scholar 

  47. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci. 1999; 892 146–154

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Humana Press, a part of Springer Science + Business Media, LLC

About this chapter

Cite this chapter

Cali, A.M.G., Caprio, S. (2008). Ectopic Fat Deposition, Adiponectin and Insulin Resistance in Obese Adolescents. In: Zeitler, P.S., Nadeau, K.J. (eds) Insulin Resistance. Contemporary Endocrinology. Humana Press. https://doi.org/10.1007/978-1-59745-192-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-192-5_9

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-875-1

  • Online ISBN: 978-1-59745-192-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics